Independent NDC12 resource · Not affiliated with the FDA

Regulatory facts linked to current FDA sources  View FDA source

The Future of the National Drug Code

Prepare Your Organization For NDC12

Latest news, expert guidance, and practical resources to help healthcare and pharmaceutical teams understand NDC12, prepare for the FDA’s uniform 12-digit National Drug Code format, and plan for the March 7, 2033 transition.
Days
Hours
Minutes
Seconds

During the 2033–2036 labeling transition, affected systems should be able to handle both 10-digit and 12-digit FDA-assigned NDCs.

NEW FDA FORMAT
12 Digits
UNIFORM STRUCTURE
6-4-2
RULE EFFECTIVE
March 7, 2033
LABEL TRANSITION ENDS
March 6, 2036
What’s Changing

Latest News & Updates

Follow the latest regulatory developments, standards activity, industry guidance, and implementation updates related to the transition to NDC12.

Events

The Real Work on NDC12 Is About to Start!

The transition to a 12-digit NDC is entering a new phase. Industry attention is moving beyond the rule itself and toward implementation. As organizations begin to align, areas of friction will start to emerge.
Industry News

The NDC12 Final Rule Is Here

The FDA has issued the final rule revising the 12-digit National Drug Code (NDC12) format. This confirms the format and establishes a date for implementation.
Events

NDC12 Stops Being Theory at HDA DMC

On March 10, 2026 - the NDC12 conversation moves from awareness to execution at the HDA Distribution Management Conference (DMC). Follow this blog for an overview of the session and a final recap once it's completed.
Prepare for NDC12

Start Your NDC12 Readiness Assessment

Identify where NDC12 may affect your systems, data, labeling, workflows, vendors, and trading partners. Use the assessment to understand your current readiness, uncover high-risk dependencies, and determine what your organization should investigate next.
Quick Answers

Common Questions About NDC12

Get concise answers to common questions about the FDA’s 12-digit National Drug Code format, including the 6-4-2 structure, implementation dates, NDC10 conversion, NDC11, labeling, and organizational readiness.

NDC12 is the FDA’s uniform 12-digit National Drug Code format. It uses a fixed 6-4-2 structure consisting of a six-digit labeler code, four-digit product code, and two-digit package code.

The final rule takes effect on March 7, 2033. FDA will begin assigning new NDCs in the 12-digit format and converting previously assigned FDA NDCs to the new structure on that date.
The first six digits identify the labeler, the next four identify the product, and the final two identify the package size and type.
The FDA final rule changes FDA-assigned NDCs. It does not itself revise the separate HIPAA transaction standards that currently use an 11-digit NDC representation for reimbursement.
Organizations that assign, store, exchange, display, print, scan, validate, or otherwise process FDA-assigned NDCs should assess their readiness.
Stay Updated

Stay Informed as NDC12 Develops

Receive important NDC12 updates, regulatory developments, implementation guidance, and new resources directly by email.